Skip to main content

Remote Job Finders (RJF)

Rising Amid Flurry of CAR T Deals, Stylus Proves Cell Therapy Is Not Dead

Stylus Medicine, a member of BioSpace’s NextGen Class of 2026, launched in May 2025 to develop new, less complex genetic medicines. The company’s in vivo approach has attracted “intense” interest from Big Pharma.

Nonprofit Aims To Modernize Manufacturing by Clearing Capital Hurdle

Industry groups have identified upfront costs as a barrier to streamlining U.S. drugmaking. The nonprofit API Innovation Center has a proposed answer for how to tilt finances in favor of investments in continuous manufacturing.
Scroll to top